Ani işitme kaybi sonuçlarimiz ve kurtarma tedavisinde hiperbarik oksijenin yeri

Year 2016, Volume: 8 Issue: 4, 190 - 194, 29.11.2016

Caner Kılıç

https://doi.org/10.21601/ortadogutipdergisi.271334

Abstract

Amaç: Bu çalışmada ani
işitme kaybı tanısı konulan hastalara uyguladığımız tedaviler sonuçlarıyla
sunulmuştur.

Yöntem
ve Gereçler: 2014-
2015 yılları arasında ani işitme kaybı tanısı konulan 19’ u (%54) erkek, 16’ sı
(%46) kadın 35 hasta çalışmaya alındı. Tüm hastalara aynı medikal tedavi
protokolu uygulandı. Beşinci gün sonunda işitmede düzelme olmayan hastalar
hiperbarik oksijen tedavisine yönlendirildi. Sonuçta işitme kaybı, iyileşme
düzeyine göre sınıflandırıldı.

Bulgular:
Hastaların
yaşları 25-54 arasında, ortanca yaş 39,514 (± 8,139) idi. Tedavinin 1.  gününde çekilen odiometride 7 hastanın (%20)
eşiklerinde belirgin düzelme görüldü. 
Hiperbarik oksijen tedavisi (HBO₂) alan 11 hastanın (%31) 10’
unda (%91) orta düzeyde iyileşme, toplamda 17 hastada  (%49) tam iyileşme, 6 hastada (%17) belirgin
iyileşme, 10 hastada (%28) orta iyileşme düzeyi 
görüldü. 1 hastada (%2) ise iyileşme olmadı.

 

Sonuçlar:
 Hastaların tamamına yakınında
uygulanan tedavi protokolünden yarar sağladığı görülmüştür. Ayrıca prognozdaki
yararı göz ardı edilmeksizin HBO_2, tedavinin erken yada geç oduğuna
bakılmaksızın streoide ek olarak kullanılmasını önermekteyiz.

 

Keywords

hiperbarik oksijen, işitme kaybı, steroid

Our results on sudden hearing loss and hyperbaric oxygen therapy role in recovery

Abstract

Objective: In this study, we
describe the treatments applied to patients diagnosed with sudden hearing loss
along with the observed treatment results.

Materials
and Methods:
A total of 35 patients diagnosed with sudden hearing loss between 2014 and
2015, and consisting of 19 (54%) males and 16 (46%) females, were included into
the study. The same medical treatment protocol was applied to all patients.
Patients who failed to show any improvement by the end of the fifth day of
treatment were subjected to hyperbaric oxygen treatment. Patients were
classified according to the level of hearing loss recovery they exhibited.

Results: The age of the
patients ranged between 25 and 54, while the median age was 35.828. An
Audiometric evaluation taken on the first day of treatment showed a significant
improvement in the hearing threshold of 7 (20%) of the patients. Of the 11
patients who received hyperbaric oxygen treatment (HBO₂), 10 (91%)
exhibited moderate recovery. On the other hand, among the total of 35 patients
included into the study, 17 (49%) showed full recovery, 6 (17%) showed
significant recovery, and 10 (28%) showed moderate recovery. One (2%) of the
patients did not exhibit any recovery.

Conclusion: It was observed that
nearly all of the patients benefited from the administered treatment protocol.
In addition, considering its benefits on patient prognosis, we also recommend
the use of steroid in addition HBO2 treatment, regardless of whether it is
applied at an early or late stage of the treatment.

 

Keywords

hyperbaric oxygen, hearing loss, steroid

References

• Pitaro J, Bechor-Fellner A Gavriel H, Marom T, Eviatar E. Sudden sensorineural hearing loss in children: Etiology, management, and outcome. Int J Pediatr Otorhinolaryngol 2016;82:34-7.
• Kallinen J, Laurikainen E, Laippala P, Grenman R. Sudden deafness: a comparision of anticoagulant therapy and carbogen inhalation therapy. An Otol Rhinol Laryngol 1997;106:22-26.
• Chung JH, Lee SH, Park CW, Kim C, Park JK, Shin JH. Clinical significance of arterial stiffness in idiopathic sudden sensorineural hearing loss. Laryngoscope 2016 Jan 4. doi: 10.1002
• Durmuş K, Terzi H, Karataş TD, Doğan M, Uysal IÖ, Şencan M, Altuntaş EE. Assessment of Hematological Factors Involved in Development and Prognosis of Idiopathic SuddenSensorineural Hearing Loss. J Craniofac Surg 2016;27(1):85-91
• Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT. Effectiveness of intratympanic dexamethasone injection in suddendeafness patients as salvage treatment. Laryngoscope 2004;114:1184– 1189
• Hong SM, Park CH, Lee JH. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg 2009;141:579–583
• Landreau P, Bonhoure JB, Chabrol A. Sudden deafness : different pathologies and results of treatment by normovolemic hemodilution. Rev Laryngol Otol Rhinol 1991:112(2):185-188
• Eisenman DJ, Arts HA. Efectiveness of treatmend for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000;126:1161-1164
• Zhang DB, Zheng ND. Metastatic Adenocarcinoma of Unknown Primary in the Bilateral Cerebellopontine Angles: Case Report and Review of the Literature. Turk Neurosurg 2015;25(6):936-9.
• Koçyiğit M, Ormancı N, Ertaş B, Akpek E. Spinal anestezi sonrası işitme kaybı Hearing loss after spinal anesthesia. Ege Tıp Derg 2013;52(3):172-174
• Chae SW, Cho JH, Lee JH, Kang HJ, Hwang SJ. Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome. J Laryngol Otol 2002;116(4):291-3.
• Diao M, Tian F, Sun J Sudden sensorineural hearing loss as the first manifestation of chronic myeloid leukaemia: case report. J Laryngol 2014;128(11):1015-7
• Hugess GB, Freedman MA, Haberkamp TJ, et al. Sudden sensorineural hearing loss. Otolaryngol Clin North Am 1996;29:393-405.
• Wilkins SA Jr, Mattox DE, Lyles A. Evaluation of a “shotgun”regimen for sudden hearing loss. Otolaryngol Head Neck Surg 1987;97:474-80.
• Gianoli GJ, Li JC. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2001;125:142-146
• Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatmentof idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29(4):453-60.
• Lee JB, Choi SJ. Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss. Otolaryngol Head Neck Surg 2016;154(2):328-34.
• Yilmaz HB, Erdogan RB, Paksoy M, Sanli A. Sudden hearing loss and vertigo after tooth extraction successfully treated with combined therapy including HBO2: a case report. Undersea Hyperb Med 2015;42(6):603-6.
• Pezzoli M, Magnano M, Maffi L, Pezzoli L, Marcato P, Orione M, et. al. Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study. Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1659-66.
• Agrawal S, Sharma N. Complete recovery following hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss--a report of two cases. Undersea Hyperb Med. 2016 Mar-Apr;43(2):161-6.
• Carneiro SN, Guerreiro DV, Cunha AM, Camacho ÓF, Aguiar IC. Hyperbaric oxygen therapy in sudden sensorineural hearing loss following spinal anesthesia: case reports. Undersea Hyperb Med. 2016 Mar-Apr;43(2):153-9.
• Capuano L, Cavaliere M, Parente G, Damiano A, Pezzuti G, Lopardo D, et.al. Hyperbaric oxygen for idiopathic sudden hearing loss: is the routine application helpful? Acta Otolaryngol 2015 Jul;135(7):692-7.
• Chen J, Liang J, Ou J, Cai W. Mental health in adults with sudden sensorineural hearing loss: an assessment of depressive symptoms and its correlates. J Psychosom Res 2013;75(1):72- 74
• Oya R, Horii A, Akazawa H, Osaki Y, Inohara H. Prognostic predictors of sudden sensorineural hearing loss in defibrinogenation therapy. Acta Otolaryngol 2016;136(3):271-6